1,200
Participants
Start Date
September 26, 2024
Primary Completion Date
December 30, 2027
Study Completion Date
December 30, 2027
Research Site, Beijing
Research Site, Chengdu
Research Site, Fuzhou
Research Site, Guangzhou
Research Site, Guiyang
Research Site, Harbin
Research Site, Hebei
Research Site, Henan
Research Site, Inner Mongolia
Research Site, Jiangsu
Research Site, Lanzhou
Research Site, Nanning
Research Site, Qingdao
Research Site, Taiyuan
Research Site, Tianjin
Research Site, Ürümqi
Research Site, Wenzhou
Research Site, Wuhan
Research Site, Xi'an
Research Site, Yinchuan
Lead Sponsor
AstraZeneca
INDUSTRY